Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC004895

Drug Information
Name5-amino-1,3,4-thiadiazole-2-sulfonamide
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C2H4N4O2S2/c3-1-5-6-2(9-1)10(4,7)8/h(H2,3,5)(H2,4,7,8)
InChIKeyVGMVBPQOACUDRU-UHFFFAOYSA-N
Canonical SMILESC1(=NN=C(S1)S(=O)(=O)N)N    
TargetCarbonic anhydrase 15Inhibitor[1]
Carbonic anhydrase IInhibitor[2]
Carbonic anhydrase IIInhibitor[2]
Carbonic anhydrase IVInhibitor[1]
Carbonic anhydrase IXInhibitor[1]
Carbonic anhydrase VIInhibitor[1]
Carbonic anhydrase XIIInhibitor[1]
Carbonic anhydrase XIVInhibitor[1]
Ref 1Bioorg Med Chem Lett. 2010 Aug 1;20(15):4376-81. Epub 2010 Jun 17.Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. To Reference
Ref 2Eur J Med Chem. 2010 Nov;45(11):4769-73. Epub 2010 Jul 24.Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543